Dipyridamole thallium-201 imaging versus dobutamine echocardiography for the evaluation of coronary artery disease in patients unable to exercise
- 1 December 1993
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 72 (17) , 1257-1262
- https://doi.org/10.1016/0002-9149(93)90293-l
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiographyThe American Journal of Cardiology, 1992
- Accuracy of dobutamine stress echocardiography in detecting coronary artery diseaseThe American Journal of Cardiology, 1992
- Dobutamine digital echocardiography for detecting coronary artery diseaseThe American Journal of Cardiology, 1991
- Prevalence and correlates of increased lung/heart ratio of thallium-201 during dipyridamole stress imaging for suspected coronary artery diseaseThe American Journal of Cardiology, 1990
- Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic eventsThe American Journal of Cardiology, 1990
- Predictive value of quantitative dipyridamole-thallium scintigraphy in assessing cardiovascular risk after vascular surgery in diabetes mellitusThe American Journal of Cardiology, 1989
- A look at 15 years of planar thallium-201 imagingAmerican Heart Journal, 1989
- Usefulness of the severity and extent of reversible perfusion defects during thallium-dipyridamole imaging for cardiac risk assessment before noncardiac surgeryThe American Journal of Cardiology, 1989
- Determination of Cardiac Risk by Dipyridamole-Thallium Imaging before Peripheral Vascular SurgeryNew England Journal of Medicine, 1985
- Dipyridamole–Thallium-201 Scintigraphy in the Prediction of Future Cardiac Events after Acute Myocardial InfarctionNew England Journal of Medicine, 1984